Expert consensus on prescribing restrictions that prevent primary care providers (PCPs) in Europe from initiating single-inhaler triple therapy (SITT)
Chronic Obstructive Pulmonary Disease (COPD) is a progressive condition that places a significant burden on patients and healthcare systems. Guidelines recommend triple therapy for patients with moderate-to-severe COPD whose disease remains inadequately controlled despite receiving dual therapy. This can be delivered either via multiple inhalers (MITT) or a single inhaler (SITT). SITT has been shown Read More >
What are the common barriers to optimal COPD care?
Chronic obstructive pulmonary disease (COPD) is a preventable, progressive respiratory disease, characterized by irreversible airflow limitation and symptoms such as dyspnoea, persistent cough, and sputum production. COPD was the third leading cause of mortality worldwide in 2019 (1), responsible for 3.23 million deaths (2). Despite the availability of the Global Initiative for Chronic Obstructive Lung Read More >